Detalhe da pesquisa
1.
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.
Br J Haematol
; 201(4): 718-724, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786170
2.
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
Int J Mol Sci
; 24(12)2023 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373496
3.
A Dual Role for FADD in Human Precursor T-Cell Neoplasms.
Int J Mol Sci
; 23(23)2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499482
4.
Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells.
Carcinogenesis
; 41(8): 1113-1122, 2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734690
5.
S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.
Carcinogenesis
; 40(10): 1260-1268, 2019 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805584
6.
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.
Br J Haematol
; 202(3): 693-698, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264982
7.
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
BMC Cancer
; 18(1): 430, 2018 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29661169
8.
Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development.
Carcinogenesis
; 34(4): 902-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23288923
9.
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
Nat Commun
; 14(1): 3130, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253733
10.
EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas.
Carcinogenesis
; 33(2): 452-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22114070
11.
Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.
Carcinogenesis
; 31(12): 2165-71, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20889682
12.
A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.
Cancer Res
; 67(11): 5107-16, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545588
13.
FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications.
Cancers (Basel)
; 11(10)2019 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31569512
14.
Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
Sci Rep
; 9(1): 5179, 2019 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30914738
15.
Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
Oncogene
; 38(23): 4620-4636, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742097
16.
Genetically modified mouse models in cancer studies.
Clin Transl Oncol
; 10(12): 794-803, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19068450
17.
Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
Oncotarget
; 7(38): 61485-61499, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27556297
18.
Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.
J Natl Cancer Inst
; 107(6): djv077, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855725
19.
Targeting the Fas/FasL signaling pathway in cancer therapy.
Expert Opin Ther Targets
; 16(1): 85-101, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22239437
20.
A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.
Cancer Res
; 69(6): 2577-87, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19244132